🚚 FREE U.S. Shipping on Orders Over $500
SKU: IGF1-LR3-1mg

IGF-1 LR3 (1mg)

IGF-1 LR3 (Long R3 IGF-1) is an 83-residue analogue of insulin-like growth factor 1. It differs from native IGF-1 by a 13-residue N-terminal extension and substitution of arginine for glutamic acid at position 3 of the IGF-1 sequence. The molecule contains six cysteine residues forming three intramolecular disulfide bonds, and correct disulfide pairing is required for the folded structure.

In published literature, the arginine substitution has been described as reducing affinity for the insulin-like growth factor binding proteins (IGFBPs) relative to native IGF-1. This material is supplied as a characterized reference protein for non-clinical laboratory work, such as IGF-1 receptor binding assays, IGFBP competitive binding studies, immunoassay calibration, disulfide mapping and folding verification, SDS-PAGE and size exclusion characterization, and in vitro cell proliferation assays.

Compound Specifications

  • Sequence: MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPA KSA
  • Sequence Length: 83 residues
  • Molecular Formula: C₄₀₀H₆₂₅N₁₁₁O₁₁₅S₉
  • Molecular Weight: ~9117.5 g/mol
  • Disulfide Bonds: 3 intramolecular
  • CAS Number: 946870-92-4
  • Physical Form: Lyophilized powder

 

Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

 

$135.00

Choose Quantity

Description

IGF-1 LR3 (Long R3 IGF-1) is an 83-residue analogue of insulin-like growth factor 1. It differs from native IGF-1 by a 13-residue N-terminal extension and substitution of arginine for glutamic acid at position 3 of the IGF-1 sequence. The molecule contains six cysteine residues forming three intramolecular disulfide bonds, and correct disulfide pairing is required for the folded structure.

In published literature, the arginine substitution has been described as reducing affinity for the insulin-like growth factor binding proteins (IGFBPs) relative to native IGF-1. This material is supplied as a characterized reference protein for non-clinical laboratory work, such as IGF-1 receptor binding assays, IGFBP competitive binding studies, immunoassay calibration, disulfide mapping and folding verification, SDS-PAGE and size exclusion characterization, and in vitro cell proliferation assays.

Compound Specifications

  • Sequence: MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPA KSA
  • Sequence Length: 83 residues
  • Molecular Formula: C₄₀₀H₆₂₅N₁₁₁O₁₁₅S₉
  • Molecular Weight: ~9117.5 g/mol
  • Disulfide Bonds: 3 intramolecular
  • CAS Number: 946870-92-4
  • Physical Form: Lyophilized powder

 

Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

 

Additional information

Weight 0.1 lbs
Dimensions 1 × 1 × 2 in

Disclaimer: For Research Purposes Only

This content is supplied exclusively for research and educational purposes. Nothing presented here should be interpreted as approval, promotion, or encouragement of any non-laboratory use, improper handling, or non-research application of peptides intended for scientific investigation. Any references to specific peptides, their properties, or findings associated with them are provided solely as informational research content. This information does not constitute legal advice, clinical guidance, or a recommendation for personal, therapeutic, or non-research use. These compounds are intended only for controlled scientific work conducted by qualified and authorized individuals. Before making any decision regarding the purchase, possession, handling, or use of research peptides, consultation with qualified research professionals or legal counsel is strongly advised. All information should be used responsibly, ethically, and only in connection with legitimate academic, scientific, or investigative purposes. This notice applies broadly to all peptide-related content provided here and may be updated as needed.

0